| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 187 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 187 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 187 |
| 3 | TACROLIMUS | 124 |
| 4 | CYTARABINE | 120 |
| 5 | PREDNISONE | 119 |
| 6 | MYCOPHENOLATE MOFETIL | 115 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 115 |
| 8 | ETOPOSIDE | 111 |
| 9 | METHOTREXATE SODIUM | 110 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HELIOX | 1 | 0.0256 |
| 1 | COAGULATION FACTOR VIIA RECOMBINANT HUMAN | 1 | 0.0108 |
| 2 | RELACORILANT | 1 | 0.0101 |
| 3 | ABACAVIR AND LAMIVUDINE | 2 | 0.0100 |
| 4 | BIVALIRUDIN | 6 | 0.0060 |
| 5 | INTERLEUKIN-10 | 2 | 0.0056 |
| 6 | CASTOR OIL | 1 | 0.0052 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 42 | 0.0050 |
| 8 | MITOXANTRONE HYDROCHLORIDE | 29 | 0.0046 |
| 9 | L-TRYPTOPHAN | 2 | 0.0045 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 336 |
| 1 | Alkylating Drug [EPC] | 223 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 191 |
| 3 | Topoisomerase Inhibitor [EPC] | 111 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 108 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 102 |
| 6 | Azole Antifungal [EPC] | 98 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 87 |
| 8 | Platinum-based Drug [EPC] | 82 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 73 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 4 | 0.0031 |
| 1 | CD33-directed Immunoconjugate [EPC] | 11 | 0.0030 |
| 2 | Anthracycline Topoisomerase Inhibitor [EPC] | 6 | 0.0025 |
| 3 | Anti-coagulant [EPC] | 6 | 0.0016 |
| 4 | Topoisomerase Inhibitor [EPC] | 111 | 0.0014 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 30 | 0.0013 |
| 6 | Osmotic Diuretic [EPC] | 6 | 0.0011 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 14 | 0.0011 |
| 8 | Vitamin K [EPC] | 9 | 0.0010 |
| 9 | Anthelmintic [EPC] | 3 | 0.0010 |